Calcibon® – Health Professionals - GrupoFarma Ecuador

https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/GrupoFarma-Ecuador-Producto-Suplemento-Vitamina-Calcibon-D-1-320x126.jpg
GrupoFarma-Ecuador-Producto-Suplemento-Vitamina-Calcibon-D-2
GrupoFarma-Ecuador-Producto-Suplemento-Vitamina-Calcibon-D-3

Composition
Calcium Citrate 1,500 mg (equivalent to 315 mg of elemental calcium).
Vitamin D3 800 IU.

Presentation

  • Bottle x 30 tablets.
  • Bottle x 60 tablets.

Indications

  • Nutritional supplement of calcium citrate and vitamin D indicated as an adjunct in the treatment and prevention of Osteoporosis and Osteopenia.
  • Fracture risk reduction
  • Reduced bone loss

Posology
1 to 2 tablets a day.

Contraindications
Hypersensitivity to the components of the formula, hypervitaminosis, nephrocalcinosis. Prolonged immobilization accompanied by hypercalciuria and/or hypercalcaemia.

Adverse Effects
In case of prolonged treatment or very high doses, hypercalcaemia and hypercalciuria, hypophosphatemia, kidney stones may be observed.

https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/GrupoFarma-Ecuador-Producto-Ginecologico-Calcibon-Natal-Forte-1-320x110.jpg
GrupoFarma-Ecuador-Producto-Ginecologico-Calcibon-Natal-Forte-2
GrupoFarma-Ecuador-Producto-Ginecologico-Calcibon-Natal-Forte-3

Composition

  • Calcium citrate 950 mg (equivalent to 200 mg of elemental calcium)
  • Vitamin D3 400 IU
  • Folic Acid 400 mcg
  • Elemental Iron 18 mg (ferrous fumarate)

Presentation
Bottle x 30 coated tablets.

Indications
Nutritional supplement of calcium, vitamin D3, folic acid and iron ideal for the patient before, during and after pregnancy.

Dosage
1 to 2 tablets a day.

Contraindications
Hypersensitivity to any of its components. Hypercalcaemia, hypercalciuria. Administer with caution in patients with lithiasis or renal insufficiency. Avoid concomitant administration with digitalis. Before starting treatment, pernicious anemia should be ruled out, folic acid can mask it.

https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/GrupoFarma-Ecuador-Producto-GGinecologico-Calcibon-Soya-1-320x149.jpg
GrupoFarma-Ecuador-Producto-GGinecologico-Calcibon-Soya-2
GrupoFarma-Ecuador-Producto-GGinecologico-Calcibon-Soya-3

Composition

  • Calcium citrate 950 mg (equivalent to 200 mg of elemental calcium)
  • Vitamin D3 400 IU
  • Magnesium Oxide 83 mg (equivalent to 50 mg of Magnesium Ion)
  • Soy Isoflavones 50 mg of isoflavones

Presentation
Bottle x 30 coated tablets.

Indications
Nutritional supplement in postmenopausal women. Prevention and treatment of osteoporosis, control of climacteric symptoms. (45 – 55 years)

Dosage
1 to 2 tablets per day

Contraindications
Hypercalcaemia, hypercalciuria. Administer with caution in patients with lithiasis or renal insufficiency. Avoid concomitant administration with digitalis.

Adverse Effects
Thiazide diuretics decrease renal calcium excretion, and therefore, their association with calcium supplements can cause hypercalcaemia. Concomitant administration of any calcium salt with iron supplements, tetracyclines, and alendronate should be avoided to avoid decreased bioavailability; It is suggested to administer at different times. Corticosteroids decrease calcium absorption, and estrogens increase it. Calcium supplements decrease the absorption of phenytoin.

https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/Grupo-Farma-del-Ecuador.png
https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/Grupo-Farma-del-Ecuador.png
https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/Grupo-Farma-del-Ecuador-Footer.png

¡Accompanying you and your health!
We improve the level in the health of our community, through advanced medicines, own or internationally licensed.

Subscribe

Text text.

[contact-form-7 404 "Not Found"]
Applauz

As the pioneer of the lean startup movement, APPLAUZ has dedicated it’s time to sharing effective business strategies that help new businesses and enterpreneurs put their money to work in the right way.

The information provided on this website was prepared by GrupoFarma S.A. and directed exclusively to medical personnel and health professionals. It may NOT be considered general use for people, nor as medical advice, recommendations or medical advice of any kind. We suggest not to self-medicate and consult your doctor beforehand about any concerns related to the information on the products or drugs mentioned here. Laboratories Farma S.A. will not be responsible for the misuse that third parties may give to the information obtained here.